PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
26-Feb-2022 CD Bioparticles Launches Ficolls to Support Bio-research CD Bioparticles
26-Feb-2022 CD Bioparticles Launches Conjugated Gold Nanostars for Research Use CD Bioparticles
26-Feb-2022 Creative Diagnostics Introduces the Launch of Recombinant Helicobacter Pylori Antigens Creative Diagnostics
23-Feb-2022 New Phase 2b Data Show the Majority of Adults with Moderately to Severely Active Ulcerative Colitis Achieved Clinical Response with TREMFYA®▼ (guselkumab) at 12 Weeks Janssen
23-Feb-2022 Results of Novel Clinical Study Show Adults with Moderately to Severely Active Ulcerative Colitis Achieved Higher Rates of Clinical Response, Clinical Remission, and Endoscopic Improvement at 12 Weeks with Guselkumab▼ and Golimumab Combination Therapy Versus Either Monotherapy Alone Janssen
23-Feb-2022 The Majority of Adults with Moderately to Severely Active Crohn’s Disease in a Phase 2 Study Achieved Clinical Remission and Corticosteroid-Free Remission Through 48 Weeks with TREMFYA®▼ (guselkumab) Janssen
22-Feb-2022 Europe’s Only Parallel Trade Conference returns for its 16th Year SMi Group
22-Feb-2022 CD Genomics: Bioinformatics-Analysis Division Provides Genotyping Analysis Service for Studying Genetic Variations CD Genomics
22-Feb-2022 MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service CD Genomics
21-Feb-2022 CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients CD Formulation
17-Feb-2022 INVESTIGATING THE WASTE IN OUR CELLS: SO THAT WE CAN SOON FORGET ABOUT ALZHEIMER’S University of Vienna
16-Feb-2022 Top 5 Pharma Looks to LifeSphere IDMP for Regulatory Readiness ArisGlobal
16-Feb-2022 Mechanical Properties of Biological Tissues Described the Easy Way Karl Landsteiner University of Health Sciences
15-Feb-2022 Passive or Active? Supply chain leaders compare key pharmaceutical cold chain technologies in latest white paper Tower Cold Chain
15-Feb-2022 Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer The Janssen Pharmaceutical Companies of Johnson & Johnson
11-Feb-2022 CD Formulation: A Leading Manufacturer of Excipients for Pharmaceutical Preparation CD Formulation
09-Feb-2022 IDT UNVEILS NEW SOLUTION TO ACCELERATE HOMOLOGY-DIRECTED REPAIR GENOME EDITING RESEARCH Integrated DNA Technologies
09-Feb-2022 Alfa Chemistry—A Supplier of Active Pharmaceutical Ingredients Alfa Chemistry
08-Feb-2022 DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development DuPont
03-Feb-2022 PENTAX Medical Europe launches premium solution PlasmaTYPHOON+ PENTAX Medical Europe